What Is The Vaccine That Bahrain And The Uae Have Authorized For Emergency Use Against Corona?

The "Sinopharma" vaccine for Coronavirus is approaching the end of its third experimental phase in Egypt, Bahrain and Jordan, in conjunction with Bahrain and the UAE announcing their licenses for emergency use in fighting the epidemic.

The candidate vaccine, which is close to being fully approved for treating the virus, is part of a partnership between Sinopharma China National Biotech Group and Group 42, an artificial intelligence technology company, headquartered in Abu Dhabi, United Arab Emirates.

According to a report in the medical journal "The Lancet", the results of clinical trials for the first and second stages revealed the success of the Chinese vaccine in achieving a safe and immune response, as it was given to more than 600 healthy adults, and none of them suffered from a negative reaction, and the pain of injection was It is the most common, and all of them have produced proven antibodies against the Coronavirus.

The Chinese Sinopharm has two candidate vaccines in the final stages. The results of the trials showed that adults over the age of 60 took longer to boost immunity, but were completely safe from the side effects of the vaccine.

The magazine revealed that the potential vaccine from Sinoform is an inactivated vaccine, that is, it contains the virus, which was created in the laboratory and then killed, and therefore it is not contagious, pointing out that the inactivated vaccines have a history of successful use, from facing influenza, to measles and disease Dog, but it does not provide as strong immunity as live vaccines, so it may be necessary to take several doses over time.

The Bahrain News Agency said that the Minister of Health, Sawa bint Saeed, announced the approval of the emergency use of one of the candidate vaccines for the Corona virus for frontline workers, after weeks of the UAE’s permission in September for a similar procedure that would allow the emergency use of the same vaccine for frontline personnel at high risk of infection. With the emerging corona virus.

It is reported that official Chinese media announced earlier that the potential vaccine to treat the Corona virus, which is being developed by Sinopharma, will not cost more than a thousand yuan, or $ 144, for the two doses.

 

SOURCE: ALQABAS

Comments Post Comment

Leave a Comment

Submit